aubagio 14 mg filmtabletten
sanofi-aventis (suisse) sa - teriflunomidum - filmtabletten - teriflunomidum 14 mg, color.: e 132, excipiens pro compresso dunst. - traitement des patients adultes et des patients pédiatriques de 10 ans et plus présentant des formes récurrentes-rémittentes de sclérose en plaques (sep) - synthetika
teriflunomid actavis 14 mg filmtabletten
actavis group ptc ehf - teriflunomid -
teruma 14 mg filmtabletten
teva b.v. - teriflunomid -
framasnoa 14 mg filmtabletten
sigillata limited - teriflunomid -
idmatuselo 14 mg filmtabletten
sigillata limited - teriflunomid -
rumovonde 14 mg filmtabletten
sigillata limited - teriflunomid -
teriflunomid ratiopharm 14 mg filmtabletten
teva b.v. - teriflunomid -
aubagio
sanofi winthrop industrie - teriflunomide - multiple sklerose - selektive immunsuppressiva - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
aubagio 14 mg qod filmtabletten
sanofi-aventis (suisse) sa - teriflunomidum - filmtabletten - comprimé pelliculé: teriflunomidum 14 mg, color.: e 132, excipiens pro compresso obducto. - traitement des patients adultes et des patients pédiatriques de 10 ans et plus présentant des formes récurrentes-rémittentes de sclérose en plaques (sep) - synthetika
teriflunomide mylan
mylan pharmaceuticals limited - teriflunomide - multiple sklerose, schubförmig-remittierender - immunsuppressiva - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).